Hodgkin-limfóma: vizsgálatok itt: Spanyolország
26 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy of MEN1703 in Patients with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma
- Where
- Barcelona, Madrid, Majadahonda, Murcia, Pamplona, Salamanca, Sevilla, Zaragoza
- Életkor
- 18 év and over
- People
- 118 worldwide
- Run by
- Ryvu Therapeutics S.A.
See details and how to join2024-513098-31-00 · EU 2024-513098-31-00 - 1/2. fázisTaking peopleA Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Where
- Badalona, Barcelona, Madrid, Málaga
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00 - 1/2. fázisTaking peopleA first time in man study to look at the safety of the experimental drug CCS1477 and what effects it has on cancers that affect the blood, bone marrow, lymph and lymphatic system.
- Where
- Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Valencia
- Életkor
- 18 év and over
- People
- 16
- Run by
- Cellcentric Limited
See details and how to join2024-519498-20-00 · EU 2024-519498-20-00 - 1/2. fázisTaking peopleA Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Where
- Barcelona, Madrid
- Életkor
- Up to 17 év
- People
- 37 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2023-504264-41-00 · EU 2023-504264-41-00 - 1. fázisCsak meghívásosA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Barcelona, Madrid, Pamplona, Salamanca
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 1. fázisTaking peopleA Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Where
- L'Hospitalet de Llobregat, Madrid
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07226843 · EU 2025-523601-16-00 - 1. fázisTaking peopleA Study of ARC-02 in B-cell NHL
- Where
- Barcelona, Cáceres, Madrid, Sevilla
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00 - 1/2. fázisTaking peopleA Phase 1/2a Study of UCART20x22 in B-Cell Non-Hodgkin Lymphoma [NatHaLi-01]
- Where
- Barcelona, Pamplona, Salamanca, Valencia
- Életkor
- 18 év and over
- People
- 48 worldwide
- Run by
- Cellectis
See details and how to joinNCT05607420 · EU 2022-501607-27-00 - 1. fázisTaking peopleAn early Phase 1b Study to assess how safe and effective is the treatment with drugs, called Mosunetuzumab or Glofitamab in Combination with drugs called, CC-220 and CC-99282 in Patients with B-Cell Non-Hodgkin Lymphoma.
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Salamanca, Valencia
- Életkor
- 18 év and over
- People
- 52 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2023-505185-28-00 · EU 2023-505185-28-00 - 1. fázisNot yet taking people in SpanyolországA First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona
- Életkor
- 18 év and over
- People
- 34 worldwide
- Run by
- Kyowa Kirin Inc.
See details and how to joinNCT07192471 · EU 2025-522523-96-00 - 2. fázisTaking peopleSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Where
- Barcelona, Madrid, Pozuelo de Alarcón
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00 - 1/2. fázisTaking peopleAZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Where
- L'Hospitalet de Llobregat, Madrid
- Életkor
- 12 év and over
- People
- 161 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00 - 1. fázisTaking peopleA Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Where
- Barcelona, Madrid
- Életkor
- 0 év to 18 év
- People
- 30 worldwide
- Run by
- Autolus Limited
See details and how to joinNCT06173518 · EU 2023-506307-26-00 - 3. fázisTaking peopleA Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Where
- Badalona, Cáceres, Madrid, Pamplona, Valencia, Clinica Universidad De Navarra, Hospital Universitario Quironsalud Madrid
- Életkor
- 18 év and over
- People
- 49 worldwide
- Run by
- Grifols Biologicals, LLC
See details and how to joinNCT07582432 · EU 2026-526803-31-00 - 1/2. fázisTaking peopleA study to evaluate safety and clinical activity of GSK5926371 in adult participants with relapsed or refractory B-NHL
- Where
- Barcelona, Madrid, Salamanca, Valencia
- Életkor
- 18 év and over
- People
- 30 worldwide
- Run by
- Glaxosmithkline Research & Development Limited
See details and how to join2025-524915-36-00 · EU 2025-524915-36-00 - 1. fázisTaking peopleA Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer Agents in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
- Where
- L'Hospitalet de Llobregat, Madrid, Salamanca, Valencia
- Életkor
- 18 év and over
- People
- 121 worldwide
- Run by
- ADC Therapeutics SA
See details and how to joinNCT04970901 · EU 2024-512089-32-00 - 3. fázisTaking peopleA long-term follow-up study for patients treated with Galapagos CAR T cell therapies
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 309 worldwide
- Run by
- Lakefront Biotherapeutics
See details and how to join2023-510173-34-00 · EU 2023-510173-34-00 - 1. fázisTaking peopleA Trial to Study if REGN5837 in Combination with Odronextamab is Safe for Adult Participants with Aggressive B-cell Non-Hodgkin Lymphomas
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 42 worldwide
- Run by
- Regeneron Pharmaceuticals Inc.
See details and how to joinNCT05685173 · EU 2022-502137-26-00 - 3. fázisTaking peopleBrentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Where
- Barcelona, L'Hospitalet de Llobregat, Pamplona
- Életkor
- 16 év to 69 év
- People
- 1042 worldwide
- Run by
- University College, London
See details and how to joinNCT04685616 · EU 2022-500031-37-00 - 3. fázisTaking peopleA trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.
- Where
- Granada, Madrid, Pamplona
- Életkor
- 18 év and over
- People
- 132 worldwide
- Run by
- Regeneron Pharmaceuticals Inc.
See details and how to joinNCT06230224 · EU 2022-502783-21-00 - 1/2. fázisTaking peoplePhase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcyRIIB), in Combination with Rituximab With or Without Acalabrutinib in Subjects with Indolent B-Cell Non-Hodgkin Lymphoma That Has Relapsed or is Refractory to Rituximab
- Where
- Badalona, Barcelona, El Palmar, Murcia, L'Hospitalet de Llobregat, Madrid, Sevilla
- Életkor
- 18 év and over
- People
- 23 worldwide
- Run by
- BioInvent International AB
See details and how to joinNCT03571568 · EU 2024-512972-36-00 - 2/3. fázisTaking peopleA Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
- Where
- Esplugues de Llobregat, Madrid, Valencia
- Életkor
- Up to 25 év
- People
- 210 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT05991388 · EU 2024-510575-38-00 - 1. fázisTaking peopleStudy of SGR-1505 in Mature B-Cell Neoplasms
- Where
- L'Hospitalet de Llobregat, Madrid, Pamplona, Pozuelo de Alarcón, Salamanca
- Életkor
- 18 év and over
- People
- 98 worldwide
- Run by
- Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00 - 1/2. fázisTaking peopleIMMUNOTHERAPY WITH DIFFERENTIATED T CELLS, ADULTS, AUTOLOGOUS, FROM PERIPHERAL BLOOD, SELECTED BY CD62L EXPRESSION, EXPANDED AND TRANSDUCED (GENETICALLY MODIFIED) THROUGH A LENTIVIRAL VECTOR TO EXPRESS A CHIMERIC RECEPTOR WITH ANTI-CD19 SPECIFICITY ASSOCIATED WITH CO-STIMULATORY SEQUENCES 4-1-BB AND CD3Ζ IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA.
- Where
- Barcelona, Sevilla
- Életkor
- 18 év and over
- People
- 40
- Run by
- Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
See details and how to join2024-519790-19-00 · EU 2024-519790-19-00 - 2. fázisTaking peopleRadiation-Free Therapy for the Initial treatment of Good prognosis early non-bulky HL, defined by a low Metabolic Tumor Volume and a negative interim PET after 2 chemotherapy cycles- RAFTING
- Where
- Badalona, Barcelona, Burgos, León, L'Hospitalet de Llobregat, Madrid, Oviedo, Palma, Salamanca, Santander, Sevilla
- Életkor
- 18 év and over
- People
- 145 worldwide
- Run by
- Medical University Of Gdansk
See details and how to join2024-515063-66-00 · EU 2024-515063-66-00